nodes	percent_of_prediction	percent_of_DWPC	metapath
Zidovudine—Nucleoside Analog—Azathioprine—multiple sclerosis	0.398	1	CiPCiCtD
Zidovudine—Idoxuridine—Cladribine—multiple sclerosis	0.0741	0.256	CrCrCtD
Zidovudine—Telbivudine—Cladribine—multiple sclerosis	0.0741	0.256	CrCrCtD
Zidovudine—Trifluridine—Cladribine—multiple sclerosis	0.0741	0.256	CrCrCtD
Zidovudine—Floxuridine—Cladribine—multiple sclerosis	0.0674	0.233	CrCrCtD
Zidovudine—ALB—multiple sclerosis	0.0564	1	CbGaD
Zidovudine—SLC22A2—Cladribine—multiple sclerosis	0.0215	0.117	CbGbCtD
Zidovudine—ABCG2—Cladribine—multiple sclerosis	0.0159	0.0866	CbGbCtD
Zidovudine—ABCG2—Mitoxantrone—multiple sclerosis	0.0116	0.0632	CbGbCtD
Zidovudine—CYP2A6—Prednisolone—multiple sclerosis	0.011	0.0601	CbGbCtD
Zidovudine—SLC22A11—Methotrexate—multiple sclerosis	0.00963	0.0526	CbGbCtD
Zidovudine—SLC22A7—Methotrexate—multiple sclerosis	0.00917	0.0501	CbGbCtD
Zidovudine—ABCC4—Methotrexate—multiple sclerosis	0.00896	0.049	CbGbCtD
Zidovudine—ALB—Prednisone—multiple sclerosis	0.00662	0.0362	CbGbCtD
Zidovudine—CYP2A6—Dexamethasone—multiple sclerosis	0.00648	0.0354	CbGbCtD
Zidovudine—ABCG2—Dexamethasone—multiple sclerosis	0.006	0.0328	CbGbCtD
Zidovudine—ABCB1—Methylprednisolone—multiple sclerosis	0.00572	0.0312	CbGbCtD
Zidovudine—SLC22A8—Methotrexate—multiple sclerosis	0.0056	0.0306	CbGbCtD
Zidovudine—CYP3A4—Fingolimod—multiple sclerosis	0.00532	0.029	CbGbCtD
Zidovudine—ABCG2—Methotrexate—multiple sclerosis	0.00482	0.0263	CbGbCtD
Zidovudine—CYP2C19—Prednisone—multiple sclerosis	0.00429	0.0235	CbGbCtD
Zidovudine—ABCB1—Mitoxantrone—multiple sclerosis	0.00417	0.0228	CbGbCtD
Zidovudine—SLC22A6—Methotrexate—multiple sclerosis	0.0039	0.0213	CbGbCtD
Zidovudine—ABCB1—Betamethasone—multiple sclerosis	0.00372	0.0203	CbGbCtD
Zidovudine—ABCB1—Prednisolone—multiple sclerosis	0.00367	0.02	CbGbCtD
Zidovudine—ABCB1—Prednisone—multiple sclerosis	0.00346	0.0189	CbGbCtD
Zidovudine—CYP3A4—Methylprednisolone—multiple sclerosis	0.00343	0.0187	CbGbCtD
Zidovudine—ALB—Methotrexate—multiple sclerosis	0.00332	0.0182	CbGbCtD
Zidovudine—CYP2C8—Dexamethasone—multiple sclerosis	0.0032	0.0175	CbGbCtD
Zidovudine—CYP2C19—Dexamethasone—multiple sclerosis	0.00268	0.0146	CbGbCtD
Zidovudine—CYP3A4—Triamcinolone—multiple sclerosis	0.0026	0.0142	CbGbCtD
Zidovudine—CYP3A4—Mitoxantrone—multiple sclerosis	0.0025	0.0137	CbGbCtD
Zidovudine—CYP2C9—Dexamethasone—multiple sclerosis	0.00223	0.0122	CbGbCtD
Zidovudine—CYP3A4—Betamethasone—multiple sclerosis	0.00223	0.0122	CbGbCtD
Zidovudine—CYP3A4—Prednisolone—multiple sclerosis	0.0022	0.012	CbGbCtD
Zidovudine—ABCB1—Dexamethasone—multiple sclerosis	0.00216	0.0118	CbGbCtD
Zidovudine—CYP3A4—Prednisone—multiple sclerosis	0.00208	0.0113	CbGbCtD
Zidovudine—ABCB1—Methotrexate—multiple sclerosis	0.00174	0.0095	CbGbCtD
Zidovudine—CYP3A4—Dexamethasone—multiple sclerosis	0.0013	0.00708	CbGbCtD
Zidovudine—TK1—Azacitidine—Cladribine—multiple sclerosis	0.000681	1	CbGdCrCtD
Zidovudine—TERT—nervous system—multiple sclerosis	0.000174	0.0861	CbGeAlD
Zidovudine—TERT—central nervous system—multiple sclerosis	0.000168	0.0829	CbGeAlD
Zidovudine—TERT—brain—multiple sclerosis	0.000133	0.0658	CbGeAlD
Zidovudine—TK1—nervous system—multiple sclerosis	0.00012	0.0592	CbGeAlD
Zidovudine—TK1—central nervous system—multiple sclerosis	0.000116	0.057	CbGeAlD
Zidovudine—ABCC5—retina—multiple sclerosis	9.88e-05	0.0487	CbGeAlD
Zidovudine—SLC29A2—cerebellum—multiple sclerosis	9.35e-05	0.0461	CbGeAlD
Zidovudine—TK1—brain—multiple sclerosis	9.18e-05	0.0453	CbGeAlD
Zidovudine—SLC29A2—brain—multiple sclerosis	7.59e-05	0.0374	CbGeAlD
Zidovudine—ABCC5—medulla oblongata—multiple sclerosis	7.14e-05	0.0352	CbGeAlD
Zidovudine—ABCC5—midbrain—multiple sclerosis	6.52e-05	0.0322	CbGeAlD
Zidovudine—ABCC5—cerebellum—multiple sclerosis	5.05e-05	0.0249	CbGeAlD
Zidovudine—SLC22A7—brain—multiple sclerosis	4.88e-05	0.0241	CbGeAlD
Zidovudine—SLC22A6—brain—multiple sclerosis	4.71e-05	0.0232	CbGeAlD
Zidovudine—CYP2A6—cerebellum—multiple sclerosis	4.52e-05	0.0223	CbGeAlD
Zidovudine—Discomfort—Triamcinolone—multiple sclerosis	4.39e-05	0.000859	CcSEcCtD
Zidovudine—Discomfort—Methylprednisolone—multiple sclerosis	4.38e-05	0.000857	CcSEcCtD
Zidovudine—Headache—Azathioprine—multiple sclerosis	4.37e-05	0.000856	CcSEcCtD
Zidovudine—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	4.37e-05	0.000856	CcSEcCtD
Zidovudine—Angioedema—Dexamethasone—multiple sclerosis	4.33e-05	0.000847	CcSEcCtD
Zidovudine—Angioedema—Betamethasone—multiple sclerosis	4.33e-05	0.000847	CcSEcCtD
Zidovudine—Stomatitis—Methotrexate—multiple sclerosis	4.3e-05	0.000841	CcSEcCtD
Zidovudine—Confusional state—Methylprednisolone—multiple sclerosis	4.28e-05	0.000839	CcSEcCtD
Zidovudine—Malaise—Betamethasone—multiple sclerosis	4.27e-05	0.000836	CcSEcCtD
Zidovudine—Malaise—Dexamethasone—multiple sclerosis	4.27e-05	0.000836	CcSEcCtD
Zidovudine—Oedema—Triamcinolone—multiple sclerosis	4.26e-05	0.000834	CcSEcCtD
Zidovudine—Anaphylactic shock—Triamcinolone—multiple sclerosis	4.26e-05	0.000834	CcSEcCtD
Zidovudine—Vertigo—Betamethasone—multiple sclerosis	4.25e-05	0.000833	CcSEcCtD
Zidovudine—Vertigo—Dexamethasone—multiple sclerosis	4.25e-05	0.000833	CcSEcCtD
Zidovudine—Anaphylactic shock—Methylprednisolone—multiple sclerosis	4.25e-05	0.000832	CcSEcCtD
Zidovudine—Syncope—Betamethasone—multiple sclerosis	4.24e-05	0.000831	CcSEcCtD
Zidovudine—Syncope—Dexamethasone—multiple sclerosis	4.24e-05	0.000831	CcSEcCtD
Zidovudine—Sweating—Methotrexate—multiple sclerosis	4.23e-05	0.000828	CcSEcCtD
Zidovudine—Haematuria—Methotrexate—multiple sclerosis	4.2e-05	0.000823	CcSEcCtD
Zidovudine—Shock—Triamcinolone—multiple sclerosis	4.19e-05	0.00082	CcSEcCtD
Zidovudine—Insomnia—Prednisolone—multiple sclerosis	4.19e-05	0.00082	CcSEcCtD
Zidovudine—Shock—Methylprednisolone—multiple sclerosis	4.18e-05	0.000818	CcSEcCtD
Zidovudine—Hepatobiliary disease—Methotrexate—multiple sclerosis	4.17e-05	0.000816	CcSEcCtD
Zidovudine—Nervous system disorder—Methylprednisolone—multiple sclerosis	4.17e-05	0.000816	CcSEcCtD
Zidovudine—Loss of consciousness—Betamethasone—multiple sclerosis	4.16e-05	0.000815	CcSEcCtD
Zidovudine—Loss of consciousness—Dexamethasone—multiple sclerosis	4.16e-05	0.000815	CcSEcCtD
Zidovudine—Epistaxis—Methotrexate—multiple sclerosis	4.16e-05	0.000814	CcSEcCtD
Zidovudine—Paraesthesia—Prednisolone—multiple sclerosis	4.16e-05	0.000814	CcSEcCtD
Zidovudine—Mental disorder—Prednisone—multiple sclerosis	4.15e-05	0.000812	CcSEcCtD
Zidovudine—Nausea—Azathioprine—multiple sclerosis	4.15e-05	0.000812	CcSEcCtD
Zidovudine—Skin disorder—Methylprednisolone—multiple sclerosis	4.13e-05	0.000808	CcSEcCtD
Zidovudine—Erythema—Prednisone—multiple sclerosis	4.12e-05	0.000807	CcSEcCtD
Zidovudine—Malnutrition—Prednisone—multiple sclerosis	4.12e-05	0.000807	CcSEcCtD
Zidovudine—Hyperhidrosis—Triamcinolone—multiple sclerosis	4.12e-05	0.000806	CcSEcCtD
Zidovudine—Agranulocytosis—Methotrexate—multiple sclerosis	4.11e-05	0.000806	CcSEcCtD
Zidovudine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	4.11e-05	0.000804	CcSEcCtD
Zidovudine—Convulsion—Betamethasone—multiple sclerosis	4.1e-05	0.000803	CcSEcCtD
Zidovudine—Convulsion—Dexamethasone—multiple sclerosis	4.1e-05	0.000803	CcSEcCtD
Zidovudine—ABCC5—brain—multiple sclerosis	4.1e-05	0.0202	CbGeAlD
Zidovudine—Asthenia—Mitoxantrone—multiple sclerosis	4.05e-05	0.000793	CcSEcCtD
Zidovudine—Myalgia—Betamethasone—multiple sclerosis	4.03e-05	0.000789	CcSEcCtD
Zidovudine—Myalgia—Dexamethasone—multiple sclerosis	4.03e-05	0.000789	CcSEcCtD
Zidovudine—Anxiety—Dexamethasone—multiple sclerosis	4.02e-05	0.000786	CcSEcCtD
Zidovudine—Anxiety—Betamethasone—multiple sclerosis	4.02e-05	0.000786	CcSEcCtD
Zidovudine—Discomfort—Betamethasone—multiple sclerosis	3.98e-05	0.00078	CcSEcCtD
Zidovudine—Discomfort—Dexamethasone—multiple sclerosis	3.98e-05	0.00078	CcSEcCtD
Zidovudine—Pain—Prednisolone—multiple sclerosis	3.96e-05	0.000775	CcSEcCtD
Zidovudine—Hepatitis—Methotrexate—multiple sclerosis	3.96e-05	0.000775	CcSEcCtD
Zidovudine—Pharyngitis—Methotrexate—multiple sclerosis	3.93e-05	0.000769	CcSEcCtD
Zidovudine—Urinary tract disorder—Methotrexate—multiple sclerosis	3.91e-05	0.000765	CcSEcCtD
Zidovudine—Urethral disorder—Methotrexate—multiple sclerosis	3.88e-05	0.00076	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	3.88e-05	0.00076	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	3.87e-05	0.000758	CcSEcCtD
Zidovudine—Anaphylactic shock—Betamethasone—multiple sclerosis	3.86e-05	0.000756	CcSEcCtD
Zidovudine—Oedema—Betamethasone—multiple sclerosis	3.86e-05	0.000756	CcSEcCtD
Zidovudine—Oedema—Dexamethasone—multiple sclerosis	3.86e-05	0.000756	CcSEcCtD
Zidovudine—Anaphylactic shock—Dexamethasone—multiple sclerosis	3.86e-05	0.000756	CcSEcCtD
Zidovudine—Diarrhoea—Mitoxantrone—multiple sclerosis	3.86e-05	0.000756	CcSEcCtD
Zidovudine—Insomnia—Triamcinolone—multiple sclerosis	3.85e-05	0.000754	CcSEcCtD
Zidovudine—Insomnia—Methylprednisolone—multiple sclerosis	3.84e-05	0.000752	CcSEcCtD
Zidovudine—Ill-defined disorder—Prednisone—multiple sclerosis	3.82e-05	0.000749	CcSEcCtD
Zidovudine—Paraesthesia—Triamcinolone—multiple sclerosis	3.82e-05	0.000749	CcSEcCtD
Zidovudine—Feeling abnormal—Prednisolone—multiple sclerosis	3.82e-05	0.000747	CcSEcCtD
Zidovudine—Paraesthesia—Methylprednisolone—multiple sclerosis	3.81e-05	0.000747	CcSEcCtD
Zidovudine—Anaemia—Prednisone—multiple sclerosis	3.81e-05	0.000746	CcSEcCtD
Zidovudine—Shock—Betamethasone—multiple sclerosis	3.8e-05	0.000744	CcSEcCtD
Zidovudine—Shock—Dexamethasone—multiple sclerosis	3.8e-05	0.000744	CcSEcCtD
Zidovudine—Dyspnoea—Triamcinolone—multiple sclerosis	3.8e-05	0.000743	CcSEcCtD
Zidovudine—Nervous system disorder—Betamethasone—multiple sclerosis	3.79e-05	0.000742	CcSEcCtD
Zidovudine—Nervous system disorder—Dexamethasone—multiple sclerosis	3.79e-05	0.000742	CcSEcCtD
Zidovudine—Thrombocytopenia—Betamethasone—multiple sclerosis	3.78e-05	0.000741	CcSEcCtD
Zidovudine—Thrombocytopenia—Dexamethasone—multiple sclerosis	3.78e-05	0.000741	CcSEcCtD
Zidovudine—Angioedema—Prednisone—multiple sclerosis	3.77e-05	0.000738	CcSEcCtD
Zidovudine—Dyspepsia—Triamcinolone—multiple sclerosis	3.75e-05	0.000734	CcSEcCtD
Zidovudine—Erythema multiforme—Methotrexate—multiple sclerosis	3.74e-05	0.000733	CcSEcCtD
Zidovudine—Dyspepsia—Methylprednisolone—multiple sclerosis	3.74e-05	0.000732	CcSEcCtD
Zidovudine—Hyperhidrosis—Betamethasone—multiple sclerosis	3.73e-05	0.000731	CcSEcCtD
Zidovudine—Hyperhidrosis—Dexamethasone—multiple sclerosis	3.73e-05	0.000731	CcSEcCtD
Zidovudine—ABCC4—nervous system—multiple sclerosis	3.72e-05	0.0183	CbGeAlD
Zidovudine—Malaise—Prednisone—multiple sclerosis	3.72e-05	0.000728	CcSEcCtD
Zidovudine—Vertigo—Prednisone—multiple sclerosis	3.7e-05	0.000725	CcSEcCtD
Zidovudine—Syncope—Prednisone—multiple sclerosis	3.7e-05	0.000724	CcSEcCtD
Zidovudine—SLC22A8—nervous system—multiple sclerosis	3.69e-05	0.0182	CbGeAlD
Zidovudine—Anorexia—Dexamethasone—multiple sclerosis	3.68e-05	0.000721	CcSEcCtD
Zidovudine—Anorexia—Betamethasone—multiple sclerosis	3.68e-05	0.000721	CcSEcCtD
Zidovudine—Urticaria—Prednisolone—multiple sclerosis	3.68e-05	0.00072	CcSEcCtD
Zidovudine—CYP2A6—brain—multiple sclerosis	3.68e-05	0.0181	CbGeAlD
Zidovudine—Cardiac disorder—Methotrexate—multiple sclerosis	3.67e-05	0.000719	CcSEcCtD
Zidovudine—Fatigue—Triamcinolone—multiple sclerosis	3.67e-05	0.000719	CcSEcCtD
Zidovudine—Fatigue—Methylprednisolone—multiple sclerosis	3.66e-05	0.000717	CcSEcCtD
Zidovudine—Pain—Triamcinolone—multiple sclerosis	3.64e-05	0.000713	CcSEcCtD
Zidovudine—Loss of consciousness—Prednisone—multiple sclerosis	3.62e-05	0.000709	CcSEcCtD
Zidovudine—Vomiting—Mitoxantrone—multiple sclerosis	3.59e-05	0.000703	CcSEcCtD
Zidovudine—ABCC4—central nervous system—multiple sclerosis	3.58e-05	0.0177	CbGeAlD
Zidovudine—Convulsion—Prednisone—multiple sclerosis	3.57e-05	0.000699	CcSEcCtD
Zidovudine—Mediastinal disorder—Methotrexate—multiple sclerosis	3.57e-05	0.000698	CcSEcCtD
Zidovudine—Rash—Mitoxantrone—multiple sclerosis	3.56e-05	0.000697	CcSEcCtD
Zidovudine—Dermatitis—Mitoxantrone—multiple sclerosis	3.55e-05	0.000696	CcSEcCtD
Zidovudine—Chills—Methotrexate—multiple sclerosis	3.55e-05	0.000695	CcSEcCtD
Zidovudine—SLC22A8—central nervous system—multiple sclerosis	3.55e-05	0.0175	CbGeAlD
Zidovudine—Headache—Mitoxantrone—multiple sclerosis	3.54e-05	0.000692	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	3.52e-05	0.000689	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	3.52e-05	0.000689	CcSEcCtD
Zidovudine—Arthralgia—Prednisone—multiple sclerosis	3.51e-05	0.000687	CcSEcCtD
Zidovudine—Myalgia—Prednisone—multiple sclerosis	3.51e-05	0.000687	CcSEcCtD
Zidovudine—Feeling abnormal—Triamcinolone—multiple sclerosis	3.51e-05	0.000687	CcSEcCtD
Zidovudine—Feeling abnormal—Methylprednisolone—multiple sclerosis	3.5e-05	0.000685	CcSEcCtD
Zidovudine—Anxiety—Prednisone—multiple sclerosis	3.5e-05	0.000685	CcSEcCtD
Zidovudine—Insomnia—Betamethasone—multiple sclerosis	3.49e-05	0.000684	CcSEcCtD
Zidovudine—Insomnia—Dexamethasone—multiple sclerosis	3.49e-05	0.000684	CcSEcCtD
Zidovudine—ABCG2—medulla oblongata—multiple sclerosis	3.49e-05	0.0172	CbGeAlD
Zidovudine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	3.49e-05	0.000682	CcSEcCtD
Zidovudine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	3.47e-05	0.00068	CcSEcCtD
Zidovudine—Paraesthesia—Dexamethasone—multiple sclerosis	3.47e-05	0.000679	CcSEcCtD
Zidovudine—Paraesthesia—Betamethasone—multiple sclerosis	3.47e-05	0.000679	CcSEcCtD
Zidovudine—Discomfort—Prednisone—multiple sclerosis	3.47e-05	0.000679	CcSEcCtD
Zidovudine—Mental disorder—Methotrexate—multiple sclerosis	3.47e-05	0.000679	CcSEcCtD
Zidovudine—Malnutrition—Methotrexate—multiple sclerosis	3.45e-05	0.000675	CcSEcCtD
Zidovudine—Erythema—Methotrexate—multiple sclerosis	3.45e-05	0.000675	CcSEcCtD
Zidovudine—Dyspepsia—Dexamethasone—multiple sclerosis	3.4e-05	0.000666	CcSEcCtD
Zidovudine—Dyspepsia—Betamethasone—multiple sclerosis	3.4e-05	0.000666	CcSEcCtD
Zidovudine—Urticaria—Triamcinolone—multiple sclerosis	3.38e-05	0.000662	CcSEcCtD
Zidovudine—Urticaria—Methylprednisolone—multiple sclerosis	3.37e-05	0.000661	CcSEcCtD
Zidovudine—Dysgeusia—Methotrexate—multiple sclerosis	3.37e-05	0.000661	CcSEcCtD
Zidovudine—Body temperature increased—Triamcinolone—multiple sclerosis	3.37e-05	0.000659	CcSEcCtD
Zidovudine—Oedema—Prednisone—multiple sclerosis	3.36e-05	0.000659	CcSEcCtD
Zidovudine—Anaphylactic shock—Prednisone—multiple sclerosis	3.36e-05	0.000659	CcSEcCtD
Zidovudine—Abdominal pain—Methylprednisolone—multiple sclerosis	3.36e-05	0.000658	CcSEcCtD
Zidovudine—Decreased appetite—Dexamethasone—multiple sclerosis	3.36e-05	0.000658	CcSEcCtD
Zidovudine—Decreased appetite—Betamethasone—multiple sclerosis	3.36e-05	0.000658	CcSEcCtD
Zidovudine—Nausea—Mitoxantrone—multiple sclerosis	3.35e-05	0.000656	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Betamethasone—multiple sclerosis	3.34e-05	0.000653	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	3.34e-05	0.000653	CcSEcCtD
Zidovudine—Back pain—Methotrexate—multiple sclerosis	3.33e-05	0.000652	CcSEcCtD
Zidovudine—Fatigue—Dexamethasone—multiple sclerosis	3.33e-05	0.000652	CcSEcCtD
Zidovudine—Fatigue—Betamethasone—multiple sclerosis	3.33e-05	0.000652	CcSEcCtD
Zidovudine—Shock—Prednisone—multiple sclerosis	3.31e-05	0.000648	CcSEcCtD
Zidovudine—Pain—Betamethasone—multiple sclerosis	3.3e-05	0.000647	CcSEcCtD
Zidovudine—Pain—Dexamethasone—multiple sclerosis	3.3e-05	0.000647	CcSEcCtD
Zidovudine—Nervous system disorder—Prednisone—multiple sclerosis	3.3e-05	0.000646	CcSEcCtD
Zidovudine—Skin disorder—Prednisone—multiple sclerosis	3.27e-05	0.00064	CcSEcCtD
Zidovudine—Hyperhidrosis—Prednisone—multiple sclerosis	3.25e-05	0.000637	CcSEcCtD
Zidovudine—Anorexia—Prednisone—multiple sclerosis	3.21e-05	0.000628	CcSEcCtD
Zidovudine—Ill-defined disorder—Methotrexate—multiple sclerosis	3.2e-05	0.000626	CcSEcCtD
Zidovudine—ABCG2—midbrain—multiple sclerosis	3.19e-05	0.0157	CbGeAlD
Zidovudine—Anaemia—Methotrexate—multiple sclerosis	3.18e-05	0.000623	CcSEcCtD
Zidovudine—Feeling abnormal—Dexamethasone—multiple sclerosis	3.18e-05	0.000623	CcSEcCtD
Zidovudine—Feeling abnormal—Betamethasone—multiple sclerosis	3.18e-05	0.000623	CcSEcCtD
Zidovudine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	3.16e-05	0.000619	CcSEcCtD
Zidovudine—Gastrointestinal pain—Betamethasone—multiple sclerosis	3.16e-05	0.000619	CcSEcCtD
Zidovudine—ABCG2—spinal cord—multiple sclerosis	3.11e-05	0.0154	CbGeAlD
Zidovudine—Malaise—Methotrexate—multiple sclerosis	3.11e-05	0.000608	CcSEcCtD
Zidovudine—Vertigo—Methotrexate—multiple sclerosis	3.1e-05	0.000606	CcSEcCtD
Zidovudine—Leukopenia—Methotrexate—multiple sclerosis	3.08e-05	0.000604	CcSEcCtD
Zidovudine—Urticaria—Betamethasone—multiple sclerosis	3.07e-05	0.000601	CcSEcCtD
Zidovudine—Urticaria—Dexamethasone—multiple sclerosis	3.07e-05	0.000601	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Prednisone—multiple sclerosis	3.07e-05	0.0006	CcSEcCtD
Zidovudine—Dizziness—Prednisolone—multiple sclerosis	3.06e-05	0.000599	CcSEcCtD
Zidovudine—Asthenia—Triamcinolone—multiple sclerosis	3.05e-05	0.000598	CcSEcCtD
Zidovudine—Body temperature increased—Dexamethasone—multiple sclerosis	3.05e-05	0.000598	CcSEcCtD
Zidovudine—Body temperature increased—Betamethasone—multiple sclerosis	3.05e-05	0.000598	CcSEcCtD
Zidovudine—Abdominal pain—Dexamethasone—multiple sclerosis	3.05e-05	0.000598	CcSEcCtD
Zidovudine—Abdominal pain—Betamethasone—multiple sclerosis	3.05e-05	0.000598	CcSEcCtD
Zidovudine—Asthenia—Methylprednisolone—multiple sclerosis	3.05e-05	0.000597	CcSEcCtD
Zidovudine—Insomnia—Prednisone—multiple sclerosis	3.04e-05	0.000596	CcSEcCtD
Zidovudine—Paraesthesia—Prednisone—multiple sclerosis	3.02e-05	0.000592	CcSEcCtD
Zidovudine—Pruritus—Triamcinolone—multiple sclerosis	3.01e-05	0.00059	CcSEcCtD
Zidovudine—Cough—Methotrexate—multiple sclerosis	3.01e-05	0.000589	CcSEcCtD
Zidovudine—Pruritus—Methylprednisolone—multiple sclerosis	3.01e-05	0.000588	CcSEcCtD
Zidovudine—Convulsion—Methotrexate—multiple sclerosis	2.98e-05	0.000584	CcSEcCtD
Zidovudine—Dyspepsia—Prednisone—multiple sclerosis	2.96e-05	0.00058	CcSEcCtD
Zidovudine—ALB—brain—multiple sclerosis	2.94e-05	0.0145	CbGeAlD
Zidovudine—Arthralgia—Methotrexate—multiple sclerosis	2.93e-05	0.000574	CcSEcCtD
Zidovudine—Chest pain—Methotrexate—multiple sclerosis	2.93e-05	0.000574	CcSEcCtD
Zidovudine—Myalgia—Methotrexate—multiple sclerosis	2.93e-05	0.000574	CcSEcCtD
Zidovudine—Decreased appetite—Prednisone—multiple sclerosis	2.92e-05	0.000573	CcSEcCtD
Zidovudine—Rash—Prednisolone—multiple sclerosis	2.92e-05	0.000572	CcSEcCtD
Zidovudine—Dermatitis—Prednisolone—multiple sclerosis	2.92e-05	0.000571	CcSEcCtD
Zidovudine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	2.91e-05	0.00057	CcSEcCtD
Zidovudine—Diarrhoea—Methylprednisolone—multiple sclerosis	2.91e-05	0.000569	CcSEcCtD
Zidovudine—Fatigue—Prednisone—multiple sclerosis	2.9e-05	0.000568	CcSEcCtD
Zidovudine—Headache—Prednisolone—multiple sclerosis	2.9e-05	0.000568	CcSEcCtD
Zidovudine—Discomfort—Methotrexate—multiple sclerosis	2.9e-05	0.000567	CcSEcCtD
Zidovudine—Constipation—Prednisone—multiple sclerosis	2.88e-05	0.000563	CcSEcCtD
Zidovudine—ABCC4—brain—multiple sclerosis	2.84e-05	0.014	CbGeAlD
Zidovudine—Confusional state—Methotrexate—multiple sclerosis	2.84e-05	0.000555	CcSEcCtD
Zidovudine—SLC22A8—brain—multiple sclerosis	2.82e-05	0.0139	CbGeAlD
Zidovudine—Dizziness—Triamcinolone—multiple sclerosis	2.82e-05	0.000551	CcSEcCtD
Zidovudine—Anaphylactic shock—Methotrexate—multiple sclerosis	2.81e-05	0.000551	CcSEcCtD
Zidovudine—Dizziness—Methylprednisolone—multiple sclerosis	2.81e-05	0.00055	CcSEcCtD
Zidovudine—Feeling abnormal—Prednisone—multiple sclerosis	2.77e-05	0.000543	CcSEcCtD
Zidovudine—Asthenia—Dexamethasone—multiple sclerosis	2.77e-05	0.000543	CcSEcCtD
Zidovudine—Asthenia—Betamethasone—multiple sclerosis	2.77e-05	0.000543	CcSEcCtD
Zidovudine—Nervous system disorder—Methotrexate—multiple sclerosis	2.76e-05	0.00054	CcSEcCtD
Zidovudine—Thrombocytopenia—Methotrexate—multiple sclerosis	2.75e-05	0.000539	CcSEcCtD
Zidovudine—Gastrointestinal pain—Prednisone—multiple sclerosis	2.75e-05	0.000539	CcSEcCtD
Zidovudine—Nausea—Prednisolone—multiple sclerosis	2.75e-05	0.000538	CcSEcCtD
Zidovudine—Pruritus—Betamethasone—multiple sclerosis	2.73e-05	0.000535	CcSEcCtD
Zidovudine—Pruritus—Dexamethasone—multiple sclerosis	2.73e-05	0.000535	CcSEcCtD
Zidovudine—Skin disorder—Methotrexate—multiple sclerosis	2.73e-05	0.000535	CcSEcCtD
Zidovudine—Hyperhidrosis—Methotrexate—multiple sclerosis	2.72e-05	0.000532	CcSEcCtD
Zidovudine—Vomiting—Triamcinolone—multiple sclerosis	2.71e-05	0.00053	CcSEcCtD
Zidovudine—Vomiting—Methylprednisolone—multiple sclerosis	2.7e-05	0.000529	CcSEcCtD
Zidovudine—Rash—Triamcinolone—multiple sclerosis	2.68e-05	0.000526	CcSEcCtD
Zidovudine—Dermatitis—Triamcinolone—multiple sclerosis	2.68e-05	0.000525	CcSEcCtD
Zidovudine—Anorexia—Methotrexate—multiple sclerosis	2.68e-05	0.000525	CcSEcCtD
Zidovudine—Rash—Methylprednisolone—multiple sclerosis	2.68e-05	0.000524	CcSEcCtD
Zidovudine—Dermatitis—Methylprednisolone—multiple sclerosis	2.68e-05	0.000524	CcSEcCtD
Zidovudine—Urticaria—Prednisone—multiple sclerosis	2.67e-05	0.000523	CcSEcCtD
Zidovudine—Headache—Triamcinolone—multiple sclerosis	2.67e-05	0.000522	CcSEcCtD
Zidovudine—Headache—Methylprednisolone—multiple sclerosis	2.66e-05	0.000521	CcSEcCtD
Zidovudine—Body temperature increased—Prednisone—multiple sclerosis	2.66e-05	0.000521	CcSEcCtD
Zidovudine—Abdominal pain—Prednisone—multiple sclerosis	2.66e-05	0.000521	CcSEcCtD
Zidovudine—Diarrhoea—Dexamethasone—multiple sclerosis	2.64e-05	0.000518	CcSEcCtD
Zidovudine—Diarrhoea—Betamethasone—multiple sclerosis	2.64e-05	0.000518	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	2.56e-05	0.000502	CcSEcCtD
Zidovudine—Dizziness—Dexamethasone—multiple sclerosis	2.55e-05	0.0005	CcSEcCtD
Zidovudine—Dizziness—Betamethasone—multiple sclerosis	2.55e-05	0.0005	CcSEcCtD
Zidovudine—Insomnia—Methotrexate—multiple sclerosis	2.54e-05	0.000498	CcSEcCtD
Zidovudine—Nausea—Triamcinolone—multiple sclerosis	2.53e-05	0.000495	CcSEcCtD
Zidovudine—Paraesthesia—Methotrexate—multiple sclerosis	2.52e-05	0.000494	CcSEcCtD
Zidovudine—Nausea—Methylprednisolone—multiple sclerosis	2.52e-05	0.000494	CcSEcCtD
Zidovudine—Dyspnoea—Methotrexate—multiple sclerosis	2.51e-05	0.000491	CcSEcCtD
Zidovudine—Somnolence—Methotrexate—multiple sclerosis	2.5e-05	0.000489	CcSEcCtD
Zidovudine—Dyspepsia—Methotrexate—multiple sclerosis	2.48e-05	0.000485	CcSEcCtD
Zidovudine—ABCG2—cerebellum—multiple sclerosis	2.47e-05	0.0122	CbGeAlD
Zidovudine—Vomiting—Dexamethasone—multiple sclerosis	2.46e-05	0.000481	CcSEcCtD
Zidovudine—Vomiting—Betamethasone—multiple sclerosis	2.46e-05	0.000481	CcSEcCtD
Zidovudine—Decreased appetite—Methotrexate—multiple sclerosis	2.44e-05	0.000479	CcSEcCtD
Zidovudine—Rash—Dexamethasone—multiple sclerosis	2.44e-05	0.000477	CcSEcCtD
Zidovudine—Rash—Betamethasone—multiple sclerosis	2.44e-05	0.000477	CcSEcCtD
Zidovudine—Dermatitis—Betamethasone—multiple sclerosis	2.43e-05	0.000476	CcSEcCtD
Zidovudine—Dermatitis—Dexamethasone—multiple sclerosis	2.43e-05	0.000476	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Methotrexate—multiple sclerosis	2.43e-05	0.000475	CcSEcCtD
Zidovudine—Fatigue—Methotrexate—multiple sclerosis	2.42e-05	0.000475	CcSEcCtD
Zidovudine—Headache—Dexamethasone—multiple sclerosis	2.42e-05	0.000474	CcSEcCtD
Zidovudine—Headache—Betamethasone—multiple sclerosis	2.42e-05	0.000474	CcSEcCtD
Zidovudine—Asthenia—Prednisone—multiple sclerosis	2.41e-05	0.000473	CcSEcCtD
Zidovudine—Pain—Methotrexate—multiple sclerosis	2.4e-05	0.000471	CcSEcCtD
Zidovudine—ABCB1—retina—multiple sclerosis	2.38e-05	0.0118	CbGeAlD
Zidovudine—Pruritus—Prednisone—multiple sclerosis	2.38e-05	0.000466	CcSEcCtD
Zidovudine—Feeling abnormal—Methotrexate—multiple sclerosis	2.32e-05	0.000454	CcSEcCtD
Zidovudine—Diarrhoea—Prednisone—multiple sclerosis	2.3e-05	0.000451	CcSEcCtD
Zidovudine—Gastrointestinal pain—Methotrexate—multiple sclerosis	2.3e-05	0.00045	CcSEcCtD
Zidovudine—Nausea—Dexamethasone—multiple sclerosis	2.29e-05	0.000449	CcSEcCtD
Zidovudine—Nausea—Betamethasone—multiple sclerosis	2.29e-05	0.000449	CcSEcCtD
Zidovudine—Urticaria—Methotrexate—multiple sclerosis	2.23e-05	0.000437	CcSEcCtD
Zidovudine—Dizziness—Prednisone—multiple sclerosis	2.22e-05	0.000436	CcSEcCtD
Zidovudine—Body temperature increased—Methotrexate—multiple sclerosis	2.22e-05	0.000435	CcSEcCtD
Zidovudine—Abdominal pain—Methotrexate—multiple sclerosis	2.22e-05	0.000435	CcSEcCtD
Zidovudine—Vomiting—Prednisone—multiple sclerosis	2.14e-05	0.000419	CcSEcCtD
Zidovudine—Rash—Prednisone—multiple sclerosis	2.12e-05	0.000415	CcSEcCtD
Zidovudine—Dermatitis—Prednisone—multiple sclerosis	2.12e-05	0.000415	CcSEcCtD
Zidovudine—Headache—Prednisone—multiple sclerosis	2.11e-05	0.000413	CcSEcCtD
Zidovudine—CYP2C8—brain—multiple sclerosis	2.06e-05	0.0102	CbGeAlD
Zidovudine—Asthenia—Methotrexate—multiple sclerosis	2.02e-05	0.000395	CcSEcCtD
Zidovudine—ABCG2—brain—multiple sclerosis	2.01e-05	0.00989	CbGeAlD
Zidovudine—Nausea—Prednisone—multiple sclerosis	2e-05	0.000391	CcSEcCtD
Zidovudine—Pruritus—Methotrexate—multiple sclerosis	1.99e-05	0.000389	CcSEcCtD
Zidovudine—Diarrhoea—Methotrexate—multiple sclerosis	1.92e-05	0.000377	CcSEcCtD
Zidovudine—Dizziness—Methotrexate—multiple sclerosis	1.86e-05	0.000364	CcSEcCtD
Zidovudine—CYP3A4—nervous system—multiple sclerosis	1.83e-05	0.00902	CbGeAlD
Zidovudine—Vomiting—Methotrexate—multiple sclerosis	1.79e-05	0.00035	CcSEcCtD
Zidovudine—Rash—Methotrexate—multiple sclerosis	1.77e-05	0.000347	CcSEcCtD
Zidovudine—Dermatitis—Methotrexate—multiple sclerosis	1.77e-05	0.000347	CcSEcCtD
Zidovudine—Headache—Methotrexate—multiple sclerosis	1.76e-05	0.000345	CcSEcCtD
Zidovudine—CYP3A4—central nervous system—multiple sclerosis	1.76e-05	0.00868	CbGeAlD
Zidovudine—ABCB1—medulla oblongata—multiple sclerosis	1.72e-05	0.0085	CbGeAlD
Zidovudine—Nausea—Methotrexate—multiple sclerosis	1.67e-05	0.000327	CcSEcCtD
Zidovudine—ABCB1—midbrain—multiple sclerosis	1.57e-05	0.00777	CbGeAlD
Zidovudine—ABCB1—spinal cord—multiple sclerosis	1.54e-05	0.00758	CbGeAlD
Zidovudine—SLC22A6—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.47e-05	0.000753	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—SRM—multiple sclerosis	1.44e-05	0.00074	CbGpPWpGaD
Zidovudine—ALB—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	1.44e-05	0.000739	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—SRM—multiple sclerosis	1.43e-05	0.000732	CbGpPWpGaD
Zidovudine—TERT—Disease—APOE—multiple sclerosis	1.42e-05	0.000728	CbGpPWpGaD
Zidovudine—ABCC5—Disease—RPL5—multiple sclerosis	1.42e-05	0.000728	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—ITGA4—multiple sclerosis	1.42e-05	0.000728	CbGpPWpGaD
Zidovudine—ABCB1—Allograft Rejection—CD80—multiple sclerosis	1.42e-05	0.000727	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	1.42e-05	0.000726	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	1.42e-05	0.000726	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—CXCL10—multiple sclerosis	1.41e-05	0.000723	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—IFNB1—multiple sclerosis	1.41e-05	0.000723	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	1.41e-05	0.000722	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	1.41e-05	0.000722	CbGpPWpGaD
Zidovudine—ABCG2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.4e-05	0.000717	CbGpPWpGaD
Zidovudine—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	1.4e-05	0.000715	CbGpPWpGaD
Zidovudine—SLC22A2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.39e-05	0.00071	CbGpPWpGaD
Zidovudine—ALB—Selenium Micronutrient Network—CCL2—multiple sclerosis	1.38e-05	0.000708	CbGpPWpGaD
Zidovudine—TERT—Cell Cycle—MYC—multiple sclerosis	1.38e-05	0.000705	CbGpPWpGaD
Zidovudine—ABCC4—Platelet activation, signaling and aggregation—ALB—multiple sclerosis	1.36e-05	0.000698	CbGpPWpGaD
Zidovudine—ABCC5—Disease—SLC11A1—multiple sclerosis	1.36e-05	0.000698	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—GPC5—multiple sclerosis	1.35e-05	0.000692	CbGpPWpGaD
Zidovudine—TERT—Cell Cycle—MAPK1—multiple sclerosis	1.35e-05	0.00069	CbGpPWpGaD
Zidovudine—ALB—Folate Metabolism—IL1B—multiple sclerosis	1.32e-05	0.000676	CbGpPWpGaD
Zidovudine—TK1—Metabolism—APOE—multiple sclerosis	1.32e-05	0.000675	CbGpPWpGaD
Zidovudine—ALB—Folate Metabolism—IL2—multiple sclerosis	1.31e-05	0.000673	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—SRM—multiple sclerosis	1.31e-05	0.000672	CbGpPWpGaD
Zidovudine—ABCB1—nervous system—multiple sclerosis	1.29e-05	0.00638	CbGeAlD
Zidovudine—TERT—Disease—CD80—multiple sclerosis	1.29e-05	0.000659	CbGpPWpGaD
Zidovudine—UGT2B7—NRF2 pathway—TGFB1—multiple sclerosis	1.28e-05	0.000654	CbGpPWpGaD
Zidovudine—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	1.27e-05	0.000652	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	1.27e-05	0.000648	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	1.27e-05	0.000648	CbGpPWpGaD
Zidovudine—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	1.26e-05	0.000647	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—PLEK—multiple sclerosis	1.26e-05	0.000647	CbGpPWpGaD
Zidovudine—ABCC4—Ectoderm Differentiation—MYC—multiple sclerosis	1.26e-05	0.000645	CbGpPWpGaD
Zidovudine—SLC22A8—SLC-mediated transmembrane transport—ALB—multiple sclerosis	1.25e-05	0.000639	CbGpPWpGaD
Zidovudine—ABCB1—central nervous system—multiple sclerosis	1.25e-05	0.00615	CbGeAlD
Zidovudine—ABCG2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.24e-05	0.000634	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—CD86—multiple sclerosis	1.23e-05	0.000632	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	1.23e-05	0.000629	CbGpPWpGaD
Zidovudine—SLC22A2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.23e-05	0.000627	CbGpPWpGaD
Zidovudine—ABCB1—cerebellum—multiple sclerosis	1.22e-05	0.00601	CbGeAlD
Zidovudine—CYP2A6—Biological oxidations—POMC—multiple sclerosis	1.22e-05	0.000623	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—CCL5—multiple sclerosis	1.22e-05	0.000622	CbGpPWpGaD
Zidovudine—ABCC4—NRF2 pathway—TGFB1—multiple sclerosis	1.2e-05	0.000615	CbGpPWpGaD
Zidovudine—ALB—Vitamin B12 Metabolism—TNF—multiple sclerosis	1.18e-05	0.000603	CbGpPWpGaD
Zidovudine—ALB—Selenium Micronutrient Network—IFNG—multiple sclerosis	1.17e-05	0.000602	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	1.15e-05	0.000591	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	1.15e-05	0.000591	CbGpPWpGaD
Zidovudine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	1.14e-05	0.000585	CbGpPWpGaD
Zidovudine—TK1—Metabolism—POMC—multiple sclerosis	1.13e-05	0.00058	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—SPP1—multiple sclerosis	1.13e-05	0.000576	CbGpPWpGaD
Zidovudine—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	1.12e-05	0.000575	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—RRM1—multiple sclerosis	1.12e-05	0.000573	CbGpPWpGaD
Zidovudine—ABCC4—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	1.1e-05	0.000566	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—CCR5—multiple sclerosis	1.09e-05	0.000561	CbGpPWpGaD
Zidovudine—ALB—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	1.09e-05	0.00056	CbGpPWpGaD
Zidovudine—ABCC5—Disease—CD28—multiple sclerosis	1.09e-05	0.000557	CbGpPWpGaD
Zidovudine—TERT—Disease—TYK2—multiple sclerosis	1.09e-05	0.000556	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—IL2RA—multiple sclerosis	1.08e-05	0.000553	CbGpPWpGaD
Zidovudine—ALB—Selenium Micronutrient Network—IL1B—multiple sclerosis	1.05e-05	0.000537	CbGpPWpGaD
Zidovudine—SLC22A6—SLC-mediated transmembrane transport—ALB—multiple sclerosis	1.04e-05	0.000533	CbGpPWpGaD
Zidovudine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	1.04e-05	0.00053	CbGpPWpGaD
Zidovudine—TK1—Metabolism—ALB—multiple sclerosis	1.03e-05	0.000528	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—CYP27B1—multiple sclerosis	1.02e-05	0.000521	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—CYP24A1—multiple sclerosis	1.02e-05	0.000521	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—CYP24A1—multiple sclerosis	1.01e-05	0.000516	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—CYP27B1—multiple sclerosis	1.01e-05	0.000516	CbGpPWpGaD
Zidovudine—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	1e-05	0.000513	CbGpPWpGaD
Zidovudine—ABCB1—Allograft Rejection—IL2—multiple sclerosis	9.97e-06	0.000511	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—APOE—multiple sclerosis	9.96e-06	0.00051	CbGpPWpGaD
Zidovudine—ABCB1—brain—multiple sclerosis	9.89e-06	0.00488	CbGeAlD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	9.86e-06	0.000505	CbGpPWpGaD
Zidovudine—TERT—Disease—CD4—multiple sclerosis	9.82e-06	0.000503	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—IL2RA—multiple sclerosis	9.71e-06	0.000497	CbGpPWpGaD
Zidovudine—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	9.58e-06	0.000491	CbGpPWpGaD
Zidovudine—ALB—Folate Metabolism—TNF—multiple sclerosis	9.57e-06	0.00049	CbGpPWpGaD
Zidovudine—ALB—Vitamin B12 Metabolism—IL6—multiple sclerosis	9.49e-06	0.000486	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—GPC5—multiple sclerosis	9.31e-06	0.000477	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—CYP27B1—multiple sclerosis	9.25e-06	0.000474	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—CYP24A1—multiple sclerosis	9.25e-06	0.000474	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—GPC5—multiple sclerosis	9.21e-06	0.000472	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—CD80—multiple sclerosis	9e-06	0.000461	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—SRM—multiple sclerosis	8.97e-06	0.000459	CbGpPWpGaD
Zidovudine—ALB—Metabolism—SRM—multiple sclerosis	8.91e-06	0.000457	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—SELE—multiple sclerosis	8.9e-06	0.000456	CbGpPWpGaD
Zidovudine—ALB—Platelet degranulation—TGFB1—multiple sclerosis	8.79e-06	0.00045	CbGpPWpGaD
Zidovudine—ABCC5—Transmembrane transport of small molecules—ALB—multiple sclerosis	8.77e-06	0.000449	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—BCHE—multiple sclerosis	8.72e-06	0.000446	CbGpPWpGaD
Zidovudine—SLC22A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	8.68e-06	0.000445	CbGpPWpGaD
Zidovudine—ALB—Transmembrane transport of small molecules—AQP4—multiple sclerosis	8.64e-06	0.000443	CbGpPWpGaD
Zidovudine—ABCC4—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	8.61e-06	0.000441	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—POMC—multiple sclerosis	8.56e-06	0.000438	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	8.52e-06	0.000437	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—GPC5—multiple sclerosis	8.46e-06	0.000433	CbGpPWpGaD
Zidovudine—ABCC4—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	8.45e-06	0.000433	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	8.44e-06	0.000432	CbGpPWpGaD
Zidovudine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	8.4e-06	0.00043	CbGpPWpGaD
Zidovudine—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—multiple sclerosis	8.37e-06	0.000429	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—CCL2—multiple sclerosis	8.37e-06	0.000429	CbGpPWpGaD
Zidovudine—SLC22A11—Transmembrane transport of small molecules—ALB—multiple sclerosis	8.31e-06	0.000426	CbGpPWpGaD
Zidovudine—CYP2C8—Biological oxidations—POMC—multiple sclerosis	8.31e-06	0.000426	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—SRM—multiple sclerosis	8e-06	0.00041	CbGpPWpGaD
Zidovudine—CYP2A6—NRF2 pathway—TGFB1—multiple sclerosis	8e-06	0.00041	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—SRM—multiple sclerosis	7.81e-06	0.0004	CbGpPWpGaD
Zidovudine—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	7.78e-06	0.000398	CbGpPWpGaD
Zidovudine—ABCC5—Disease—CD86—multiple sclerosis	7.76e-06	0.000397	CbGpPWpGaD
Zidovudine—ALB—Folate Metabolism—IL6—multiple sclerosis	7.72e-06	0.000396	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—RRM1—multiple sclerosis	7.71e-06	0.000395	CbGpPWpGaD
Zidovudine—ALB—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	7.64e-06	0.000391	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—RRM1—multiple sclerosis	7.63e-06	0.000391	CbGpPWpGaD
Zidovudine—ALB—Selenium Micronutrient Network—TNF—multiple sclerosis	7.6e-06	0.000389	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—TYK2—multiple sclerosis	7.6e-06	0.000389	CbGpPWpGaD
Zidovudine—TERT—Disease—STAT3—multiple sclerosis	7.6e-06	0.000389	CbGpPWpGaD
Zidovudine—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	7.57e-06	0.000388	CbGpPWpGaD
Zidovudine—SLC22A7—Transmembrane transport of small molecules—ALB—multiple sclerosis	7.54e-06	0.000386	CbGpPWpGaD
Zidovudine—CYP2C19—Biological oxidations—POMC—multiple sclerosis	7.42e-06	0.00038	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—SRM—multiple sclerosis	7.3e-06	0.000374	CbGpPWpGaD
Zidovudine—ABCB1—Allograft Rejection—TNF—multiple sclerosis	7.26e-06	0.000372	CbGpPWpGaD
Zidovudine—TERT—Disease—MYC—multiple sclerosis	7.06e-06	0.000362	CbGpPWpGaD
Zidovudine—TERT—Disease—TGFB1—multiple sclerosis	7.05e-06	0.000361	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—ALB—multiple sclerosis	7.02e-06	0.00036	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—RRM1—multiple sclerosis	7.01e-06	0.000359	CbGpPWpGaD
Zidovudine—TERT—Disease—MAPK1—multiple sclerosis	6.91e-06	0.000354	CbGpPWpGaD
Zidovudine—ABCC5—Disease—CCR5—multiple sclerosis	6.88e-06	0.000352	CbGpPWpGaD
Zidovudine—CYP2C9—Biological oxidations—POMC—multiple sclerosis	6.76e-06	0.000346	CbGpPWpGaD
Zidovudine—ABCC5—Disease—HLA-A—multiple sclerosis	6.71e-06	0.000343	CbGpPWpGaD
Zidovudine—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	6.69e-06	0.000343	CbGpPWpGaD
Zidovudine—SLC22A2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	6.64e-06	0.00034	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—ITGA4—multiple sclerosis	6.43e-06	0.000329	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—BCHE—multiple sclerosis	6.43e-06	0.000329	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—IFNB1—multiple sclerosis	6.39e-06	0.000327	CbGpPWpGaD
Zidovudine—SLC22A8—Transmembrane transport of small molecules—ALB—multiple sclerosis	6.34e-06	0.000325	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—IL2—multiple sclerosis	6.33e-06	0.000324	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	6.32e-06	0.000324	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	6.32e-06	0.000324	CbGpPWpGaD
Zidovudine—ALB—Metabolism—CYP27B1—multiple sclerosis	6.28e-06	0.000322	CbGpPWpGaD
Zidovudine—ALB—Metabolism—CYP24A1—multiple sclerosis	6.28e-06	0.000322	CbGpPWpGaD
Zidovudine—ABCC5—Disease—APOE—multiple sclerosis	6.26e-06	0.000321	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	6.17e-06	0.000316	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	6.14e-06	0.000314	CbGpPWpGaD
Zidovudine—ALB—Selenium Micronutrient Network—IL6—multiple sclerosis	6.14e-06	0.000314	CbGpPWpGaD
Zidovudine—ABCC4—Transmembrane transport of small molecules—ALB—multiple sclerosis	6.08e-06	0.000311	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—MMP9—multiple sclerosis	5.99e-06	0.000307	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—GPC5—multiple sclerosis	5.78e-06	0.000296	CbGpPWpGaD
Zidovudine—ALB—Metabolism—GPC5—multiple sclerosis	5.74e-06	0.000294	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—IL2—multiple sclerosis	5.69e-06	0.000292	CbGpPWpGaD
Zidovudine—ABCC5—Disease—CD80—multiple sclerosis	5.66e-06	0.00029	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	5.64e-06	0.000289	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	5.64e-06	0.000289	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	5.51e-06	0.000282	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—CYP24A1—multiple sclerosis	5.5e-06	0.000282	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—CYP27B1—multiple sclerosis	5.5e-06	0.000282	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—STAT3—multiple sclerosis	5.32e-06	0.000273	CbGpPWpGaD
Zidovudine—TERT—Disease—IL6—multiple sclerosis	5.31e-06	0.000272	CbGpPWpGaD
Zidovudine—SLC22A6—Transmembrane transport of small molecules—ALB—multiple sclerosis	5.29e-06	0.000271	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—APOE—multiple sclerosis	5.24e-06	0.000269	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—GPC5—multiple sclerosis	5.16e-06	0.000264	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	5.14e-06	0.000263	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	5.14e-06	0.000263	CbGpPWpGaD
Zidovudine—SLC22A2—Neuronal System—MAPK1—multiple sclerosis	5.09e-06	0.000261	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—GPC5—multiple sclerosis	5.03e-06	0.000258	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	5.02e-06	0.000257	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	5e-06	0.000256	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—MYC—multiple sclerosis	4.95e-06	0.000253	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—TGFB1—multiple sclerosis	4.93e-06	0.000253	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—MAPK1—multiple sclerosis	4.84e-06	0.000248	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—SRM—multiple sclerosis	4.81e-06	0.000246	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—RRM1—multiple sclerosis	4.79e-06	0.000245	CbGpPWpGaD
Zidovudine—ABCC5—Disease—TYK2—multiple sclerosis	4.78e-06	0.000245	CbGpPWpGaD
Zidovudine—ALB—Metabolism—RRM1—multiple sclerosis	4.76e-06	0.000244	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—GPC5—multiple sclerosis	4.7e-06	0.000241	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—POMC—multiple sclerosis	4.5e-06	0.000231	CbGpPWpGaD
Zidovudine—CYP3A4—Biological oxidations—POMC—multiple sclerosis	4.46e-06	0.000228	CbGpPWpGaD
Zidovudine—ABCG2—Transmembrane transport of small molecules—ALB—multiple sclerosis	4.46e-06	0.000228	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—TGFB1—multiple sclerosis	4.44e-06	0.000227	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—BCHE—multiple sclerosis	4.43e-06	0.000227	CbGpPWpGaD
Zidovudine—SLC22A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	4.41e-06	0.000226	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—IL2RA—multiple sclerosis	4.39e-06	0.000225	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—BCHE—multiple sclerosis	4.38e-06	0.000225	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—MAPK1—multiple sclerosis	4.35e-06	0.000223	CbGpPWpGaD
Zidovudine—ABCC5—Disease—CD4—multiple sclerosis	4.32e-06	0.000221	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—RRM1—multiple sclerosis	4.27e-06	0.000219	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—RRM1—multiple sclerosis	4.17e-06	0.000214	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—ALB—multiple sclerosis	4.11e-06	0.00021	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—BCHE—multiple sclerosis	4.02e-06	0.000206	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	3.9e-06	0.0002	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—RRM1—multiple sclerosis	3.9e-06	0.0002	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—APOE—multiple sclerosis	3.87e-06	0.000198	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	3.85e-06	0.000197	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	3.84e-06	0.000197	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	3.82e-06	0.000196	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	3.76e-06	0.000193	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—IL6—multiple sclerosis	3.72e-06	0.00019	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.71e-06	0.00019	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.69e-06	0.000189	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	3.58e-06	0.000184	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	3.39e-06	0.000174	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	3.39e-06	0.000174	CbGpPWpGaD
Zidovudine—ABCC5—Disease—STAT3—multiple sclerosis	3.35e-06	0.000171	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—POMC—multiple sclerosis	3.32e-06	0.00017	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.31e-06	0.00017	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.19e-06	0.000163	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.17e-06	0.000162	CbGpPWpGaD
Zidovudine—ABCC5—Disease—MYC—multiple sclerosis	3.11e-06	0.000159	CbGpPWpGaD
Zidovudine—ABCC5—Disease—TGFB1—multiple sclerosis	3.1e-06	0.000159	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—GPC5—multiple sclerosis	3.1e-06	0.000159	CbGpPWpGaD
Zidovudine—ABCC5—Disease—MAPK1—multiple sclerosis	3.04e-06	0.000156	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—ALB—multiple sclerosis	3.03e-06	0.000155	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.02e-06	0.000155	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.91e-06	0.000149	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.85e-06	0.000146	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—BCHE—multiple sclerosis	2.75e-06	0.000141	CbGpPWpGaD
Zidovudine—ALB—Metabolism—BCHE—multiple sclerosis	2.73e-06	0.00014	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—APOE—multiple sclerosis	2.67e-06	0.000137	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—APOE—multiple sclerosis	2.64e-06	0.000135	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.6e-06	0.000133	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.6e-06	0.000133	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—IL2—multiple sclerosis	2.58e-06	0.000132	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—RRM1—multiple sclerosis	2.57e-06	0.000132	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—BCHE—multiple sclerosis	2.45e-06	0.000126	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—APOE—multiple sclerosis	2.42e-06	0.000124	CbGpPWpGaD
Zidovudine—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.41e-06	0.000123	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—BCHE—multiple sclerosis	2.4e-06	0.000123	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.37e-06	0.000121	CbGpPWpGaD
Zidovudine—ABCC5—Disease—IL6—multiple sclerosis	2.34e-06	0.00012	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—POMC—multiple sclerosis	2.29e-06	0.000117	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—POMC—multiple sclerosis	2.27e-06	0.000116	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—BCHE—multiple sclerosis	2.24e-06	0.000115	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—ALB—multiple sclerosis	2.09e-06	0.000107	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—POMC—multiple sclerosis	2.08e-06	0.000107	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—ALB—multiple sclerosis	2.07e-06	0.000106	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—TGFB1—multiple sclerosis	2.01e-06	0.000103	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—MAPK1—multiple sclerosis	1.97e-06	0.000101	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—ALB—multiple sclerosis	1.9e-06	9.71e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—APOE—multiple sclerosis	1.65e-06	8.47e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—APOE—multiple sclerosis	1.64e-06	8.42e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—APOE—multiple sclerosis	1.48e-06	7.56e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.48e-06	7.56e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—APOE—multiple sclerosis	1.44e-06	7.38e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—POMC—multiple sclerosis	1.42e-06	7.28e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—POMC—multiple sclerosis	1.41e-06	7.24e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—APOE—multiple sclerosis	1.35e-06	6.89e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—ALB—multiple sclerosis	1.3e-06	6.63e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—POMC—multiple sclerosis	1.27e-06	6.5e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—POMC—multiple sclerosis	1.24e-06	6.34e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—POMC—multiple sclerosis	1.16e-06	5.92e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—ALB—multiple sclerosis	1.16e-06	5.92e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—ALB—multiple sclerosis	1.13e-06	5.78e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—ALB—multiple sclerosis	1.05e-06	5.4e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—APOE—multiple sclerosis	8.88e-07	4.55e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—POMC—multiple sclerosis	7.63e-07	3.91e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—ALB—multiple sclerosis	6.95e-07	3.56e-05	CbGpPWpGaD
